Abstract
The rationale behind catheter-based renal denervation is that afferent and efferent renal nerves play a role in the pathogenesis and maintenance of high blood pressure, and that this can be prevented by blocking the function of the renal nerves. Since the introduction of catheter-based renal denervation, several observational and a small number of randomised controlled trials have been conducted. The available evidence does not allow for a definitive conclusion regarding its efficacy. There have been no serious side-effects reported. The development of this treatment concept has not been finalised; new trials have just commenced or will start in the near future.
| Translated title of the contribution | Renal denervation as treatment option for hypertension |
|---|---|
| Original language | Dutch |
| Article number | D629 |
| Journal | Nederlands Tijdschrift voor Geneeskunde |
| Volume | 160 |
| Issue number | 43 |
| Publication status | Published - 2016 |